Merck & Co Inc MRK:NYSE

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
56.80 0.06   0.11%3.10%10,140,9758.3M
Market data is delayed by at least 20 minutes.
Quarterly Earnings Per Share
8/3/2014 5:29 PM ET
Market ComparisonP/E (TTM)P/E (Forward
12 Months)
PEG1 Year EPS
Growth Rate
5 Year EPS
Growth Rate
MRK
Merck & Co Inc
29.9--7.4-26.66%-16.56%
Biotechnology & Drugs
Industry
--17.37.2-19.85%5.18%
Healthcare
Sector
30.616.15.40.04%6.27%
S&P; 50018.420.73.416.78%11.99%
Loading...

Earnings Summary

On 7/29/2014, MRK reported 2 quarter 2014 earnings of $0.85 per share. This result was in-line with the consensus of the 16 analysts following the company and beat last year's 2 quarter results by 1.19%.


MRK's PE ratio is above average for the Biotechnology & Drugs industry and signals that investors are willing to pay a premium for this stock. However, during the past year, earnings growth has lagged its historical five year growth rate.